The complete nucleotide sequence of the sit gene encoding the soluble lytic transglycosylase (Slt; EC 3.2.1.-) from Escherichia coli has been determined. The largest open reading frame identified on a 2.5-kb PvuII-Sall fragment indicates that the enzyme is translated as a preprotein of either 654 or 645 amino acids, depending on which of two potential start codons is used. The two possible translation products differ only in the lengths of their predicted signal peptides, 36 or 27 amino acids, respectively. In both cases, processing results in a soluble mature protein of 618 amino acids (Mr = 70,468). The deduced primary structure of the mature protein was confirmed by N-terminal sequencing and determination of the amino acid composition of the isolated transglycosylase. The sit gene contains a high percentage of rare codons, comparable to other low-expressed genes. A hairpin structure that could serve as a transcriptional terminator is located downstream of the sit coding region and precedes the trpR open reading frame at 99.7 min on the E. coli chromosomal map. A computer-assisted search did not reveal any significant sequence similarity to other known carbohydratedegrading enzymes, including lysozymes. Interestingly, a stretch of 151 amino acids at the C terminus of the transglycosylase shows similarity to the N-terminal portion of the internal virion protein D from bacteriophage T7. Overexpression of the slt gene, under the control of the temperature-inducible phage lambda PR promoter, results in a 250-fold overproduction of the mature transglycosylase, whereas after deletion of the signal peptide a 100-fold overproduction of the enzyme is observed in the cytoplasm.
The murein polymer of the bacterial cell wall is composed of glycan strands of variable length which are cross-linked by short peptide bridges to form one macromolecule around the cell.
A whole set of murein-metabolizing enzymes in Escherichia coli has been identified (for a review, see reference 19) . The balanced action of these murein-synthesizing and -degrading enzymes determines the specific shape of the murein sacculus and consequently the shape of the bacterium (12, 38, 54) .
In E. coli, four of the nine murein-degrading enzymes that have been characterized so far are potentially capable of degrading the intact polymer and thereby lysing the cell (20) . Two of these enzymes are endopeptidases, able to cleave the peptide cross bridges of murein (47, 49) , whereas the other two are glycosylases which are able to degrade the glycan strands (18, 22, 33) .
The two glycosylases have been reported to show the same enzymatic activity but to differ with respect to their cellular localization, one of them being a soluble enzyme with a molecular mass of 65 kDa and the other being membrane bound with a molecular mass of 35 kDa (18, 22, 33) .
Both glycosylases catalyze the cleavage of the ,-1,4-glycosidic bond between N-acetylmuramic acid and N-acetylglucosamine residues, as do various lysozymes. However, the bacterial glycosylases also catalyze an intramolecular transglycosylation reaction, conserving the energy of the glycosidic bond by the synthesis of a 1,6-anhydrobond in the muramic acid residue (Fig. 1) . They are * Corresponding author. therefore known as soluble and membrane-bound transglycosylases (18, 33) . This study concerns the soluble lytic transglycosylase (Slt; EC 3.2.1.-).
Studies on bacterial transglycosylases are interesting for at least two reasons. In the first place, such studies will contribute to a better understanding of the metabolism of murein and might consequently lead to the design of selective inhibitors and thus to the development of a new class of antibiotics. The second reason is that these enzymes can be used for the production of pharmacologically active compounds by specific degradation of murein in vitro. Pharmacological activities of degradation products of murein have been demonstrated in several studies. A sleep-inducing factor, isolated from human urine (31) , turned out to be identical to one of the monomeric products (N-acetylglucosaminyl-1 ,6-anhydro-N-acetylmuramyl-L-alanyl-D-isoglutamyl-m-diaminopimelyl-D-alanine) obtained by degradation of murein with the lytic transglycosylases (18) . Picomole amounts of this compound, injected cerebro-intraventricularly, induced excess slow-wave sleep in rabbits (24) .
Furthermore, the human pathogens Bordetella pertussis and Neisseria gonorrhoeae were found to release the structurally identical 1,6-anhydromuropeptides, eliciting cytotoxic effects on ciliated epithelial cells in higher organisms (7, 8, 32, 41) .
Recently, Betzner and Keck (3) have published the cloning of the slt gene from E. coli, encoding the soluble lytic transglycosylase. They obtained a 30-fold overexpression of the slt gene. A three-step purification procedure was used to isolate the enzyme to homogeneity, and X-ray-quality crys- determine the three-dimensional structure and, especially, the structure-function relationship of the enzyme. Since large amounts of highly purified enzyme are needed for both the crystallographic work and future kinetic studies on the interesting enzymatic activity, this study includes work on overexpression of the slt gene which enabled us to isolate 100-mg amounts of the enzyme in a one-step purification procedure.
MATERIALS AND METHODS
Plasmids and bacterial strains. Plasmid pAB58, carrying the structural gene for soluble lytic transglycosylase, has been described by Betzner and Keck (3) . Plasmid vectors M13mp18 and M13mpl9 were those used by Vieira and Messing (50) . Phasmids pMa5-8 and pMc5-8 were gifts from H.-J. Fritz (43) , and plasmid pJRD187 was obtained from J. Davison (9) . Strain CJ236 was purchased from Bio-Rad Laboratories, Richmond, Calif. The helper phage M13K07 (51) was obtained from Pharmacia LKB Biotechnology Inc., Uppsala, Sweden. E. coli strains were grown in LuriaBertani medium (30) supplemented with the appropriate antibiotics.
Materials.
[3H]diaminopimelic acid-labeled murein (specific activity, 10,000 cpm/5 ,ug of murein) was a kind gift of J.-V. Holtje (Max-Planck-Institut, Tubingen, Germany).
Deoxyadenosine 5'-([a-35SIthio)triphosphate was purchased from Amersham, Aylesbury, United Kingdom. Unlabeled deoxynucleotide triphosphates were purchased from Pharmacia Laboratories (Uppsala, Sweden), and dideoxynucleotides were obtained from Boehringer, Mannheim, Germany. All restriction endonucleases, exonuclease Bal 31, T4 DNA ligase, Klenow DNA polymerase, and T4 polynucleotide kinase were purchased from Boehringer. Sequenase was obtained from United States Biochemical Corp., Cleveland, Ohio. All enzymes were used under the conditions recommended by the suppliers.
DNA isolation and transformation. Plasmid DNA was purified by cesium chloride-ethidium bromide density gradient centrifugation (30) . Small-scale plasmid DNA preparations were purified according to the alkaline extraction procedure (4). Plasmids were introduced into E. coli host strains as described previously (29) .
DNA sequencing. As a preliminary to the nucleotide sequencing of the 2.5-kb PvuII-SalI chromosomal insert from pAB58, restriction endonuclease fragments or fragments being created by exonuclease Bal 31 treatment were subcloned into M13mpl8 or M13mp19 (50) . The subclones were sequenced by the dideoxyribonucleotide chain termination reaction (37) by using Sequenase. Both strands were completely sequenced. DNA sequences were analyzed with the PC GENE program (Genofit, Geneva, Switzerland). Amino acid sequences were compared with the Swiss-Prot protein data base (EMBL, Heidelberg, Germany) by using the FastP program (27) and the method of Goad and Kanehisha (13) .
Construction of Slt overproducers. The 0.9-kb EcoRI-SalI fragment of pJRD187, carrying the thermosensitive phage lambda repressor (cI857), PR promoter, Shine-Dalgamo sequence, and ATG triplet of the phage lambda cro gene, together with a multiple cloning site, was cloned into the 3.8-kb phasmid pMa5-8 linearized with EcoRI and Sail. This resulted in a 4.6-kb plasmid (pHEMa99). The 2.5-kb PvuIISall fragment of pAB58, carrying the slt gene, was cloned into pHEMa99, which was linearized with NruI and SalI, resulting in a 7.1-kb plasmid (pHEMa112).
Site-directed mutagenesis was performed as described previously (25) . Strain CJ236 was used as a host for plasmid pHEMa112 for the incorporation of uridine, with the helper phage M13K07 for the production of single-stranded DNA (51) . Four synthetic oligonucleotides carrying Asp718 re-striction sites were synthesized on an Applied Biosystems (Warrington, United Kingdom) model 380B DNA synthesizer by Eurosequence, Groningen, The Netherlands. The first oligonucleotide was used to mutate the BamHI site of the multiple cloning site into a unique Asp718 site, resulting in the plasmid pHEMall2A. The second and third oligonucleotides facilitated cloning of the slt gene encoding the transglycosylase with a 28-or 37-amino-acid signal peptide, respectively. The fourth oligonucleotide was used for cloning the slt gene without a signal peptide-encoding sequence. The Asp718 restriction sites were characterized by restriction and nucleotide sequence analysis. The individual Asp718 fragments were then independently deleted in pHEMall2A to facilitate cloning of the slt gene downstream of the Shine-Dalgarno sequence, in frame with the ATG start codon of the cro gene, and under the control of the temperature-inducible phage lambda PR promoter. The in-frame cloning was verified by sequence analysis and resulted in the plasmids pHEMa115 (encoding Slt carrying a signal peptide of 37 amino acids), pHEMa140 (encoding Slt carrying a signal peptide of 28 amino acids), and pHEMa116 (encoding Slt without a signal peptide).
Overexpression of the sit gene. E. coli HB101, harboring pHEMa99, pHEMallS, pHEMa116, or pHEMa140, was grown in 200 ml of Luria-Bertani medium containing 100 ,ug of ampicillin per ml at 28°C. When the cultures had reached the mid-exponential growth phase (optical density at 600 nm = 0.4), the temperature was shifted to 42°C. Samples (20 ml) were withdrawn 45 and 30 min before and 0, 15, 30, and 45 min after the temperature shift and cooled on ice. Cells were collected by centrifugation (15 min, 4 ,000 x g, 4°C), resuspended in 1 ml of 10 mM Tris-maleate-NaOH buffer (pH 6.8), and lysed by ultrasonication (Vibra cell sonifier equipped with a microtip; Sonics and Materials, Danbury, Conn.) for 4 x 10 s at 100 W. Soluble fractions were obtained by centrifugation of the sonicated cell preparations (homogenates) for 1 h at 10,000 x g and 4°C.
The degree of overproduction was estimated by Western blot (immunoblot) analysis with various dilutions of the soluble fractions as described below. Host strain HB101 carrying the vector pHEMa99 served as a control.
The soluble fractions were assayed for enzymatic activity as described below.
Protein concentrations were determined by the method of Bradford (6) with bovine serum albumin as a standard.
SDS-polyacrylamide gel electrophoresis and Western blot analysis. Proteins from homogenates or soluble fractions were separated by sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis (28) . Either the proteins were stained with Coomassie brilliant blue R-250 or they were transferred to nitrocellulose filters and soluble lytic transglycosylase was stained immunochemically (5) . Polyclonal antibodies against soluble lytic transglycosylase were prepared as described previously (22) .
Isolation of soluble lytic transglycosylase. Soluble lytic transglycosylase was isolated from E. coli HB101 harboring the plasmid pHEMa115. The 10 ,000 lb/n,andMentarifued at6 100,000 (voug ofo 1h.
Trnmlycosyilbased wash islthed frome thlersoube fractio byas moutdificcocetationof prviusy3esrie protCol (18, 26 previously on the plasmid pAB58 (3). In order to determine its nucleotide sequence, subfragments of the 2.5-kb PvuIISall fragment of pAB58 were subcloned into M13 vectors and then sequenced by the Sanger dideoxy method. The sequence strategy used is depicted in Fig. 2 Promoter sequence, ribosome binding site, and transcription terminator. We have identified two possible promoter sequences upstream of the encoding region, as shown in Fig. 3 , showing significant similarity to -35 and -10 consensUs promoter sequences and classified as mediumstrength promoters (17, 34) . We do find a putative ribosome binding site upstream of the 27-amino-acid-encoding signal peptide sequence which shows homology to the consensus Shine-Dalgarno sequence (39) . However, no ribosome binding site was found upstream of the 36-amino-acid-encoding signal peptide sequence. A strong transcriptional terminator structure consisting of a GC-rich stem of 11 bp and a loop of 3 bases, followed by an AT-rich sequence, as depicted in Fig. 3 , has also been proposed as the promoter-operator region of the trpR gene, suggesting that expression of the trpR gene is autoregulatory (16) . We propose that this stable secondary structure might exhibit both functions simultaneously.
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Rare codon usage in the slt gene. It has been shown previously (23) that codon usage of 25 nonregulatory E. coli genes is not random. [23] ) in the reading frame encoding the mature Slt (Table 1) is the same as that reported for the dnaG (42), lacI (11), araC (44) , and trpR (16, 40) genes mentioned above. In the slt gene reading frame, rare codons account for 9.9% of all codons; for the dnaG, lacI, araC, and trpR genes, they account for 11.3, 10.0, 9.2, and 6.7%, respectively. The combination of unusual codons, a poor ribosome binding site, and the (B) In vitro murein degradation with soluble fractions from cells carrying the same constructed plasmids. Soluble protein (500 ng) (10,000 X g supernatant fraction of homogenate) was assayed for enzymatic activity. The release of labeled murein fragments is not strictly proportional to the amount of protein used in the assay. translation initiation codon GUG reduces both the frequency of initiation and the rate of passage of ribosomes along the mRNA and could account for the relatively low expression rate of this putative autolysin found in wild-type cells (36) .
Rare codon usage in the noncoding reading frames of the slt gene. In most E. coli proteins, the frequency of rare codons in noncoding reading frames is approximately three times that in coding reading frames (1, 23) . This relationship does not hold for the slt gene (9.9% rare codon usage in the reading frame versus 12.8 and 9.5% in the noncoding reading frames), as has been found for the dnaG (42), lacI (11), araC (44) , and trpR (16, 40 ) genes.
Regulated high-level overexpression of the slt gene. Overproducers of Slt were constructed by using the plasmid pHEMa112 (Fig. 4) . Because of the presence of the two possible translation initiation sites, we constructed Slt overproducers carrying an either 37-or 28-amino-acid signal peptide as well as Slt without a signal peptide (Fig. 5) .
A 250-fold overproduction of Slt carrying a signal peptide of 28 amino acids was achieved 45 min after temperature induction (42°C). When growth was continued at 42°C, the optical density of the culture decreased somewhat, suggesting growth inhibition and lysis of some of the cells (Fig. 6 and  7) . The overproduced Slt was almost completely processed to the mature form and localized in the soluble enzyme fraction (Fig. 7, lanes 2 and 4) . An induction ( Fig. 6 and 7) . However, in this case the cells contained about 50% unprocessed Slt (Fig. 7, lanes 5 and 6) .
In the cytoplasm, Slt can be overproduced up to 100-fold, as is also shown in Fig. 6 and 7 . The cytoplasmic Slt is enzymatically active and localized in the soluble enzyme fraction (Fig. 7, lanes 7 and 8) .
N-terminal sequence and amino acid analysis of the protein. The single-step isolation of Slt is shown in Fig. 8 (Fig. 5) . The 28-amino-acid signal peptide is efficiently processed, even when the transglycosylase is 250-fold overproduced (Fig. 7) , suggesting that minor changes at the N terminus have no effect on the processing of this signal peptide. However, the 37-amino-acid signal peptide is not efficiently processed at about the same level of overproduction (Fig. 7) , and about 50% of the overproduced enzyme is present as a preform in the sedimentable fraction. These data support the suggestion made in the previous section, i.e., that translation initiates at nucleotide 450 and not at nucleotide 423.
Physiological function of the transglycosylase. Slt has been suggested to be a cytoplasmic enzyme (18, 19, 22, 33 The physiological function of Slt remains unclear. The enzyme might play a role in recycling of muropeptides (14, 15, 20) during cell elongation and/or cell division, when cleavage of covalent bonds is required. The energy, conserved in the 1,6-anhydrobond, might be used for the formation of a new ,-1,4-glycosidic bond (18) .
Cells grow normally when the slt gene has been deleted from the chromosome (35) . It is possible that in these cells, the function of the soluble enzyme is taken over by the membrane-bound lytic transglycosylase (33) . It will be interesting to investigate whether E. coli can survive in the absence of both transglycosylases.
The massive overproduction of Slt by cells carrying the pHEMa140 or pHEMallS plasmid does not lead to lysis of the majority of the cells (Fig. 6 ). This indicates that in these cells the enzyme must, in some way, be prevented from degrading the murein polymer.
Comparison of the primary structure of transglycosylase with those of other proteins. The amino acid sequence of the soluble lytic transglycosylase from E. coli was compared with those of other proteins present in the Swiss-Prot protein sequence data base (16,941 entries) by using the FastP program (27) . Alignment with the program of Goad and Kanehisha (13) gave essentially the same result (Fig. 9) .
The primary structure of transglycosylase does not show significant similarity to those of other known carbohydratedegrading enzymes, including phage lambda endolysin (Mr = 17,500), the only protein possessing an identical enzymatic activity whose primary structure is known (21, 48) . The E. coli transglycosylase does show similarity to the internal virion protein D from bacteriophage T7 (10) . A stretch of 151 amino acids at the C terminus of Slt shows significant similarity to the N-terminal part of the internal virion protein D (Fig. 9) . About 26% of the amino acid residues in the two sequences are identical, and 71% are similar if conservative substitutions are included. The function or enzymatic activity of this protein, late expressed in the phage cycle, is not known, but it is feasible that it plays a role in lysis of the host cell by the bacteriophage. Whether the C terminus of the transglycosylase is necessary for the cleavage of the P-1,4-glycosidic bond will be studied by constructing N-and C-terminal deletions.
